Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents in USD of Sound Point Acquisition Corp I, Ltd from Q1 2021 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
Sound Point Acquisition Corp I, Ltd quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents history and change rate from Q1 2021 to Q1 2023.
  • Sound Point Acquisition Corp I, Ltd Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents for the quarter ending 31 Mar 2023 was $499K, a 65.7% decline year-over-year.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, YoY Quarterly Change (%)

Sound Point Acquisition Corp I, Ltd Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (USD)

Period Value YoY Chg Change % Date Report Filed
Q1 2023 $499K -$955K -65.7% 31 Mar 2023 10-Q 12 May 2023
Q4 2022 $623K +$598K +2393% 31 Dec 2022 10-Q 12 May 2023
Q3 2022 $837K +$812K +3248% 30 Sep 2022 10-Q 10 Nov 2022
Q2 2022 $946K +$921K +3686% 30 Jun 2022 10-Q 12 Aug 2022
Q1 2022 $1.45M +$1.45M 31 Mar 2022 10-Q 12 May 2023
Q4 2021 $25K 31 Dec 2021 10-Q 12 May 2023
Q3 2021 $25K 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 $25K 30 Jun 2021 10-Q 12 Aug 2022
Q1 2021 $0 03 May 2021 10-K 30 Mar 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.